Assertio

Assertio company information, Employees & Contact Information

Explore related pages

Related company profiles:

Assertio is a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs. Our focus is on supporting patients by marketing products in oncology, neurology, and pain management. Ticker symbol: ASRT

Company Details

Employees
63
Address
100 South Saunders Road,
Phone
5107448001
Email
in****@****med.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Lake Forest, IL
Looking for a particular Assertio employee's phone or email?

Assertio Questions

News

Assertio Holdings, Inc. to Release Q2 2025 Financial Results and Host Webcast on August 11, 2025 | ASRT Stock News - Quiver Quantitative

Assertio Holdings, Inc. to Release Q2 2025 Financial Results and Host Webcast on August 11, 2025 | ASRT Stock News Quiver Quantitative

Assertio Holdings, Inc. to Report Second Quarter 2025 Financial Results on August 11, 2025 - Yahoo Finance

Assertio Holdings, Inc. to Report Second Quarter 2025 Financial Results on August 11, 2025 Yahoo Finance

Assertio (Nasdaq: ASRT) sets Q3 results Nov. 10; expects guidance update within the current range - Stock Titan

Assertio (Nasdaq: ASRT) sets Q3 results Nov. 10; expects guidance update within the current range Stock Titan

Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study - GlobeNewswire

Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study GlobeNewswire

Assertio Announces Leadership Transition - The Manila Times

Assertio Announces Leadership Transition The Manila Times

Assertio Sets Q2 2025 Earnings Release: Management to Discuss Strategic Plans for 2025 - Stock Titan

Assertio Sets Q2 2025 Earnings Release: Management to Discuss Strategic Plans for 2025 Stock Titan

Assertio Therapeutics Agrees to Merge with Zyla Life - GlobeNewswire

Assertio Therapeutics Agrees to Merge with Zyla Life GlobeNewswire

Assertio Therapeutics Announces Sale of Gralise® for Total Transaction Value of $127.5 Million - GlobeNewswire

Assertio Therapeutics Announces Sale of Gralise® for Total Transaction Value of $127.5 Million GlobeNewswire

Depomed Inc. Announces Corporate Name Change to Assertio Therapeutics, Inc. - GlobeNewswire

Depomed Inc. Announces Corporate Name Change to Assertio Therapeutics, Inc. GlobeNewswire

Top Assertio Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant